Teva Pharmaceutical Industries

Bookmark

Add to MyYahoo RSS

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

4 hrs ago | The Miami Herald

Frost invests in drone maker

Healthcare serial entrepreneur Phillip Frost is leading an $825,000 investment in Drone Aviation Holding Corp., a Jacksonville-based drone development company.

Comment?

Related Topix: Healthcare, Biotech, Opko Health

8 hrs ago | Theflyonthewall.com

Medtronic, AbbVie reimburse executives for inversion-triggered taxes, WSJ says

Medtronic announces first implants in AdaptResponse CRT clinical trial Medtronic announced the first implants in a clinical trial that will compare patient and healthcare system outcomes in heart failure patients who have cardiac resynchronization therapy devices with the AdaptivCRT feature enabled versus patients receiving standard CRT.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Drug Enforcement Administration, Biotech, Gilead Sciences

12 hrs ago | Reuters

Teva finds positive results in advanced trials for asthma drug

Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Cephalon, Pharmaceuticals

15 hrs ago | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Now through November 4, students in grad... )--Teva Pharmaceutical Industries Ltd. announced today that reslizumab, an investigational anti-IL-5 monoclonal antibody, demonstrated clear levels of efficacy ... )--Today, The Prudential Spirit of Community Awards begins its search for Michigan's top youth volunteers of 2015.

Comment?

Related Topix: Manufacturing, Automakers, Superior Industries International, Washington DC, Biotech

Mon Sep 01, 2014

The Motley Fool

3 Reasons Teva Pharmaceutical Industries Ltd. Stock Could Rise

Generic and specialty drugmakers have been experiencing a profit bonanza as former top-selling products have lost patent protect in recent years.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Thu Aug 28, 2014

TheStreet.com

Teva Dividend Could Be Hurt by Bank of Israel's Rate Cut

TEL AVIV -- The recent decision from Bank of Israel to cut its basic cash rate to a historic low of 0.25% could also bring down the dividend payment to investors in leading Israeli companies such as Teva Pharmaceutical Industries Why? This decision may depreciate the Israeli currency, the New Israeli Shekel, against the U.S. dollar, which will ... (more)

Comment?

Related Topix: Biotech, Financial Markets, Business News

Wed Aug 27, 2014

BioSpace

Teva Pharmaceutical Industries Limited Recalls Parkinson's Disease...

Teva Pharmaceutical Industries just issued a recall of one lot of its generic Parkinson's disease combination medication, carbidopa/levodopa, over it potentially containing too much of an active pharmaceutical ingredient.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Cephalon, Parkinson's Disease, Health

Express India

India's Venus Remedies surges; to collaborate with Teva on drug

Venus will collaborate with Teva Pharmaceutical Industries Ltd to develop an anti-cancer drug, it said in a statement on Tuesday.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Pharmaceuticals

Tue Aug 26, 2014

Philly.com

American expands Phila. airport facility for cold freight

American Airlines and its merger partner, US Airways, are renovating a warehouse at Philadelphia International Airport to include refrigeration for pharmaceuticals and other health-care products.

Comment?

Related Topix: Philadelphia, PA, Biotech

Mon Aug 25, 2014

AmericanBankingNews.com

Teva Pharmaceutical Industries Ltd Receives Consensus Rating of "Buy" from Analysts

Shares of Teva Pharmaceutical Industries Ltd have received an average recommendation of "Buy" from the twenty-five analysts that are covering the stock, StockRatingsNetwork reports .

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Fri Aug 22, 2014

Bloomberg

Obama Provides Birth-Control Coverage Plan for Nonprofits

Women who work for religious nonprofits will have access to birth control at no cost under a procedure the Obama administration said would also relieve their employers of any moral objections to the coverage.

Comment?

Related Topix: US News, US Supreme Court, Biotech, Standardized Testing, Education

Sys-Con Media

Financing Strategies, Financing Packages, Recognitions, Technical...

Today, Analysts Review released its research reports regarding Aon plc , U.S. Bancorp , Ally Financial Inc. , Teva Pharmaceutical Industries Limited and Pharmacyclics Inc. .

Comment?

Related Topix: Insurance, AON, US Bancorp, Banking, Financial Services, Biotech, Startups, Pharmacyclics, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Personal Finance, Retirement

Thu Aug 21, 2014

Canada NewsWire

OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating...

"While the results of the study remain blinded to OncoGenex and Teva, we are very pleased that ENSPIRIT has passed this important early interim futility analysis," said , President and CEO of OncoGenex.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Cancer, Health, Biotech, SONUS Pharmaceuticals, OncoGenex Pharmaceuticals, Healthcare Industry, Lung Cancer

The Motley Fool

Why Teva Pharmaceutical Industries Ltd Stock Is Great For a Dividend Portfolio

I say haystack because a lot of companies have paid a dividend, be it a regular dividend or special one, over the trailing 12 months -- and not all of those dividends are exactly high quality.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Pharmaceuticals, Healthcare Industry

Tue Aug 19, 2014

The Motley Fool

3 Reasons Mylan Inc Stock Could Rise

Market highs have been a frequent occurrence so far in 2014, and the healthcare sector has been no stranger to the stock surge.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Business Wire

Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

Both Mr. Abravanel and Dr. Ariely-Portnoy have substantial expertise, experience and knowledge relevant to the Company's mission and anticipated needs.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Marijuana

Mon Aug 18, 2014

AmericanBankingNews.com

Stock Traders Purchase High Volume of Teva Pharmaceutical Industries Ltd Call Options

Teva Pharmaceutical Industries Ltd saw some unusual options trading on Monday. Investors bought 54,686 call options on the stock, Analyst Ratings.Net reports.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Thu Aug 14, 2014

Bloomberg

Soros Adds to YPF, Trims Teva, Exits Monster in Quarter

George Soros 's $28 billion family office boosted its stake in YPF SA, making Argentina's largest oil company its biggest U.S.-traded stock holding in the second quarter.

Comment?

Related Topix: Biotech, Monster, Human Resources, Soros Fund Management, Investment Services, Financial Services

Applied Clinical Trials

Alexza Pharmaceuticals Provides an Update on the Five Post-EMA Approval Studies for ADASUVE?

As part of the ADASUVE approval process with the EMA, Alexza is required to conduct five post-approval studies: a controlled study to determine ADASUVE's effect on cardiac rhythms, or a thorough QTc study, with two doses of ADASUVE - study completed and data submitted to the EMA a clinical program designed to evaluate the safety / efficacy of ... (more)

Comment?

Related Topix: Alexza Pharmaceuticals, Startups, Biotech, Marketing, Medicine, Pharmacology

Hispanic Business

Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease

For further details please see www.clinicaltrials.gov . About laquinimod Laquinimod is a once-daily oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed primarily for the treatment of relapsing-remitting MS and progressive forms of MS.

Comment?

Related Topix: Biotech, Science / Technology

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••